Entrepreneur Dr Chris Behrenbruch on taking Telix Pharma to a billion dollars, the future of nuclear medicine and more - a podcast by Stockhead
from 2021-03-08T13:06
::
::
This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX).
Further episodes of The Health Kick Podcast with Tim Boreham
Further podcasts by Stockhead
Website of Stockhead